Profile
XBIT VRTX ALNY REGN ARGX SGEN
Company Name XBiotech Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $82.32M $101.65B $58.51B $57.87B $45.27B $43.15B
Employees 0.09K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO John Simard Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
XBIT VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
XBIT VRTX ALNY REGN ARGX SGEN
Last Close $2.7 $385.735 $446.4 $563.9 $711.62 $228.74
High 52 $8.25 $516.74 $482.13 $1051.24 $768 $228.74
Low 52 $2.5 $366.54 $224.58 $482.92 $520.52 $228.74
Price vs. 52 Week High -67.27 % -25.35 % -7.41 % -46.36 % -7.34 % 0 %
Price vs. 52 Week Low 8 % 5.24 % 98.77 % 16.77 % 36.71 % 0 %
Total Return
XBIT VRTX ALNY REGN ARGX SGEN
1 Month Return -14.56 % -1.35 % -0.02 % -2.89 % -0.08 % 0 %
3 Month Return -3.57 % -12.59 % 38.28 % 8.23 % 27.04 % 0 %
6 Month Return -12.9 % -21.71 % 66.28 % -11.53 % 20.79 % 0 %
9 Month Return -28.95 % -5.63 % 87.59 % -20.85 % 13.62 % 0 %
YTD Return -31.65 % -4.21 % 89.71 % -20.84 % 15.71 % 0 %
1 Year Return -62.55 % -16.67 % 62.38 % -45.92 % 32.74 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
XBIT VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.48 % - -
Dividend Paid and Capex Coverage Ration (TTM) -44.26 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
XBIT VRTX ALNY REGN ARGX SGEN
Asset Growth -12.14 % -0.87 %
Gross Profit Growth 100 % 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year -100 % 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -4.96 % -93.69 %
Net Income Growth -56.9 % -114.8 %
Net Income 3 Yeari Growth Per Share -118.23 % -122.89 %
Net Income 5 Yeari Growth Per Share -107.37 % -145.38 %
Net Income 10 Yeari Growth Per Share -84.68 % 33.84 %
Operating Income Growth -13.23 % -106.08 %
Operating Cash Flow Growth (CFG) -65.36 % -113.93 %
Operating 3 Year CFG -143.98 % -118.65 %
Operating 5 Year CFG -116.68 % -131.3 %
Operating 10 Year CFG -175.55 % 12.43 %
EPS Growth -55.56 % -114.8 %
EPS Diluted Growth -55.56 % -114.97 %
Book Value Per Share -17.11 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -33.27 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -69.16 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 221.5 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share -100 % -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth - 116.42 %
Free Cash Flow Growth -69.05 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
XBIT VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM - 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -15.76 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -15.6 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -20.9 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100.09 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 77.01 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM - 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM - 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.92 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM - 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.82 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -0.84 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 501.64 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.26 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM - 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -3.21 29.05 -1123.36 15.05 -582.34 -81.26
Price To Operating Cash Flows Ratio TTM -3.28 26.46 -3725.3 12.31 -690.34 -93.1
Price Cash Flow Ratio TTM -3.28 26.46 -3725.3 12.31 -690.34 -93.1
Income Statement (TTM)
XBIT VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.04B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.04B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -1.26 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
XBIT VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.02B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.18B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.01B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.2B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
XBIT VRTX ALNY REGN ARGX SGEN
Net Income $-0.04B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.45
AARD Aardvark Therapeutics, Inc. Common Stock 14.03
ABCL AbCellera Biologics Inc. 4.8
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.385
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.529
ABPWW 0.0232
ABSI Absci Corporation 2.885
ABUS Arbutus Biopharma Corporation 4.4443
ABVC ABVC BioPharma, Inc. 3.095
ABVX Abivax SA American Depositary Shares 84.06
ACAD ACADIA Pharmaceuticals Inc. 21.445
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.821
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.055
ACIU AC Immune SA 3.01
ETFs With Exposure to XBIT
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00007 241.41
VTI Vanguard Total Stock Market Index Fund 0.0001 326.79
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.0001 145.095
IWN iShares Russell 2000 Value ETF 0.00018 176.185
VXF Vanguard Extended Market Index Fund 0.00077 209.6
HDG ProShares Hedge Replication ETF 0.000265603 51.0272
UWM ProShares Ultra Russell2000 0.00155512 46.185
VTHR Vanguard Russell 3000 Index Fund 0 293.19
IWC iShares Micro-Cap ETF 0.01255 148.93
URTY ProShares UltraPro Russell2000 0.001244 52.665
VTWV Vanguard Russell 2000 Value Index Fund 0.0048 155.175
VTWO Vanguard Russell 2000 Index Fund 0.00224 97.59
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 46.09
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00011 111.27
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 111.25
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00006 52.5
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00006 52.49
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.48
VALT ETFMG Sit Ultra Short ETF 0.34 48.52
AVUV Avantis U.S. Small Cap Value ETF 0 99.56
GERM ETFMG Treatments, Testing and Advancements ETF 0.48 19.1577
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.3 1.75
VTSAX Vanguard Total Stock Market Index Fund 0.0001 159.25
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00077 158.72
VITSX Vanguard Total Stock Market Index Fund 0.0001 159.28
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000325277 16.09
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00077 158.73
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 57.165
DFQTX DFA U.S. Core Equity 2 Portfolio 0 43.19
VTS.AX Vanguard US Total Market Shares Index ETF 0.0001 498
VEMPX Vanguard Extended Market Index InstlPlus 0.00077 391.69
FESM 0.02 36.375
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.0001 298.79
RSSL Global X Funds 0 95.08
RFLR Innovator ETFs Trust 0.01 27.745
Unlock